I did about two hours of walking today, in total, because of going to my office, my IT supplier and finally my dentist. Two Health points. 71 more words
Tags » Prescription Drugs
FDA approves new extended-release oxycodone with abuse-deterrent properties
Source: U.S. Food and Drug Administration
145 more words
Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
A small pilot study out of the Stanford University Medical Center which used low doses of an old drug called naltrexone seems to show that it may have new use fighting fibromyalgia pain. 449 more words